CClinicalTrials.gg
CompletedNCT05159635Updated Dec 16, 2021

Combining Active Living Programme (ALP) With Home-Use Wearable Technical Aids (WTA)

An interventional study of Active Living programme and wearable technical aids and Wearable technical aids in Stroke and Foot Drop (Acquired), sponsored by Kowloon Hospital, Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-12-16.

Sponsored by Kowloon Hospital, Hong Kong · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Feb 2018, registered Aug 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The objective of this study is to evaluate the effectiveness of adopting a home-use Wearable Technical Aids (WTA) with the structured Active Living Program (ALP) to promote community participation in young stroke patients.

Read the detailed description

Two groups of patients would receive Wearable Technical Aids Training or Wearable Technical Aids Training and structured Active Living Program (ALP) for 8 sessions.

02

Conditions studied

  • Stroke
  • Foot Drop (Acquired)

Browse trials for

Keywords

  • Wearable
03

In context

Peroneal Neuropathies

41 studies on the registry are indexed under Peroneal Neuropathies; 9 are open to participants now.

This study's enrollment of 12 is below the median of 30 across 31 interventional studies indexed under Peroneal Neuropathies.

Browse Peroneal Neuropathies studies →

Lead sponsor

Kowloon Hospital, Hong Kong is the lead sponsor of 9 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

-diagnosed with foot drop with tibialis anterior muscle strength between 1 to 3- out of 5 in manual muscle testing for more than six months due to cerebrovascular accident (CVA)

Exclusion criteria

Exclusion Criteria:

  • pre-existing orthopedic conditions affecting ambulation
  • subjects who are incompetent in giving written consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Active Living programme and wearable technical aids

    Active Living programme and wearable technical aids

    Device: Active Living programme and wearable technical aids

  • Active comparator
    Wearable technical aids

    Wearable technical aids

    Device: Wearable technical aids

Interventions

  • DeviceActive Living programme and wearable technical aids

    attend 6 weeks active living programme and apply wearable technical aids for 8 weeks.

  • DeviceWearable technical aids

    apply wearable technical aids for 8 weeks.

06

What researchers measure

Primary outcomes

  1. Change score in Stroke Adapted 30 item version of the Sickness Impact Profile (SA-SIP 30)

    The quality of life scale for the people with stroke

    Time frame: before intervention, 8 weeks (after intervention )

Secondary outcomes

  1. Change score in 10 meters walk Test

    10 meters walk time

    Time frame: before intervention,8 weeks (after intervention)

07

Study locations

1 site
  • Community Rehabilitation Service Support Centre
    Kowloon, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05159635
Lead sponsor
Kowloon Hospital, Hong Kong
Collaborators
Kwong Wah Hospital, Chinese University of Hong Kong
Responsible party
Marko Chan (Senior Occupational Therapist, Kowloon Hospital, Hong Kong) — Principal investigator
First posted
Dec 16, 2021
Start date
Feb 1, 2018
Primary completion
Jun 1, 2019
Completion
Oct 1, 2019
Last update
Dec 16, 2021

Study contacts

Marko Chan, MSc
principal investigator · Community Rehabilitation Service Supoort Centre

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion